B4-RNA
- Diagnostics
B4-RNA is an early stage company developing a liquid biopsy diagnostic for early cancer detection using a proprietary RNA repair and sequencing method that allows us to access a new biomarker category.
We are currently starting our preclinical trials and are preparing to raise funds for early 2026 so that we can continue expanding our clinical trials and launch operations in the US. Our aim is to validate our technology and prepare our company for eventual commercialization of our solution in the US via an LDT.
The company is currently based from Uruguay and has received 1.25M in funding to date. We are seeking a lead investor for a pre-series A round who can help us accelerate our trials and execute on our US-centered GTM strategy.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}